Dedicated to serving and supporting the needs of those impacted by a bleeding disorder through education, advocacy and community.
News & Events
Megan Schowengerdt, our new Development Director at VHF, has worked in the non-profit sector in various roles for over twelve years. She comes to VHF from the Leukemia & Lymphoma Society (LLS) Virginia Chapter, where she helped to manage a fundraising walk...Read more »
The Virginia Hemophilia Foundation (VHF) strives to serve and support you with education, advocacy, and community building programs that are of high quality and meet a variety of needs. We hope that you have joined us this past year at an event or are considering...Read more »
Researchers at the Boston Children’s Program in Cellular and Molecular Medicine and the Harvard Medical School recently made important discoveries relevant to the functioning of von Willebrand factor (VWF). The study, “Flow-induced Elongation of von Willebrand Factor...Read more »
Alnylam Pharmaceuticals, Inc. has reported on the death of a hemophilia A patient who had been participating in a Phase 2 open label extension study for the company’s investigational therapy fitusiran which is being developed for patients with hemophilia A and B, both...Read more »